Antiarrhythmic

9 marketed 4 in Phase 3

This page covers all Antiarrhythmic drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Potassium voltage-gated channel subfamily H member 2, Potassium channels, sodium channels, potassium channels, calcium channels.

Targets

Potassium voltage-gated channel subfamily H member 2 · Potassium channels · sodium channels, potassium channels, calcium channels · Histamine H1 receptor · Muscarinic acetylcholine receptor M2 · 5-hydroxytryptamine receptor 2B · AV node, bundle of His · hERG channel · I(f) channel · Unknown

Marketed (9)

Phase 3 pipeline (4)